DISTRICT WOMEN HOSPITAL
MUZAFFARNAGAR, UTTAR PRADESH MUZAFFARNAGAR
NQAS CERTIFIED PATHOLOGY LAB
Patient Name: MRS AASHA W/O SAGAR Ref. Dept.:
Age/Gender: 25 Y/ Female Mobile: 9084196279 Ref. By:
Order No.: 01095041 Visit Type: IPD /OT Ordered on: 10-Dec-2023 01:55 PM
LAB ID: 00000870 Sample on: 10-Dec-2023 01:55 PM
Requested Test: CBC,ABO/RH,HCV,HBSAG,PT INR,MP Reported on: 10-Dec-2023 03:00 PM
INVESTIGATION OBSERVED UNIT BIOLOGICAL REF.
VALUES INTERVAL
OT PROFILE
HEMATOLOGY
CBC
HEMOGLOBIN 13.4 gm/dl 13-17
TOTAL LEUCOCYTE COUNT 12200 /µL 4000-11000
TOTAL RBCs 5.60 /µL 3.8-4.8
MCV 65.8 fl. 80-100
MCH 24.0 pg 27-32
MCHC 36.5 g/dl
RDWR 18.1 % 11.5-14.5
RDWA 58.5 % 37-54
PLATELET COUNT 319000.0 /µL 150000-400000
MPV 9.1 % 7.4-10.4
PCT 0.29 0.10-0.28
PDW 12.7
LPCR 23.2 13-43
PCV 36.9 % 36-46
Differential % Leucocyte Counts:
Segmented Neutrophils 73.6 % 40-80
Lymphocytes 21.4 % 20-40
Mid Value 5.0 % 1-15
Differential Absolute Leucocyte Counts:
Abs. Neutrophils 9.0 thou/µL 2-7
Abs. Lymphocytes 2.6 thou/µL 1-3
Abs. Eosinophils 0.6 thou/µL 0.02-0.5
ORIGINAL FINAL REPORT REVISED REPORT Signed By Pathologist
Checked by :- Lab Technician
Page 1 of 2
DISTRICT WOMEN HOSPITAL
MUZAFFARNAGAR, UTTAR PRADESH MUZAFFARNAGAR
NQAS CERTIFIED PATHOLOGY LAB
Patient Name: MRS AASHA W/O SAGAR Ref. Dept.:
Age/Gender: 25 Y/ Female Mobile: 9084196279 Ref. By:
Order No.: 01095041 Visit Type: IPD /OT Ordered on: 10-Dec-2023 01:55 PM
LAB ID: 00000870 Sample on: 10-Dec-2023 01:55 PM
Requested Test: CBC,ABO/RH,HCV,HBSAG,PT INR,MP Reported on: 10-Dec-2023 03:00 PM
INVESTIGATION OBSERVED UNIT BIOLOGICAL REF.
VALUES INTERVAL
P-TIME (PROTHROMBIN TIME)
(PROTHROMBIN TIME)CONTROL 13.2 Sec
Photometric
(PROTHROMBIN TIME) Test 13.8 Sec 12.5-15.5
Photometric
Comments: International Normalised Ratio (INR) is the most recommendation method for monitoring of Oral anticoagulants. The dose of the
anticoagulant can be adjusted betweenthe limits by two parallel biological assays: 1-Prothrombin Time which explorates thethe extrinsic
coagulation pathway. 2-Activated partial thromboplastin time which takes into account any effect of deficiencies induced by the drug on the
intrinsic pathway.
SEROLOGY
BLOOD GROUP (ABO-RH-FACTOR)
BLOOD GROUP B
Rh Type Positive
HBSAG
HBsAg Result Non-Reactive
Immunochromatography
Comments: 1-False Positive or Negative Results may be seen during a variety of acute & chronic conditions,Low vlremia & Low Antibody titre.
2-Reactive results must be correlated with supportive clinical, historical and epidemiological evidence to arrive at a final diagnosis.
HCV
HCV RESULT Non-Reactive
Comments: 1-False Positive or Negative Results may be seen during a variety of acute & chronic conditions,Low vlremia & Low Antibody titre.
2-Reactive results must be correlated with supportive clinical, historical and epidemiological evidence to arrive at a final diagnosis.
MALARIA PARASITE (MP)
Malaria Parasite (MP) Negative
Card
--------------------------End of The Report--------------------------
ORIGINAL FINAL REPORT REVISED REPORT Signed By Pathologist
Checked by :- Lab Technician
Page 2 of 2
DISTRICT WOMEN HOSPITAL
MUZAFFARNAGAR, UTTAR PRADESH MUZAFFARNAGAR
NQAS CERTIFIED PATHOLOGY LAB
Patient Name: MRS SEEMA W/O DEEPAK Ref. Dept.:
Age/Gender: 23 Y/ Female Mobile: 7500135526 Ref. By:
Order No.: 01095040 Visit Type: IPD /OT Ordered on: 10-Dec-2023 01:54 PM
LAB ID: 00000869 Sample on: 10-Dec-2023 01:54 PM
Requested Test: PT INR Reported on: 10-Dec-2023 03:00 PM
INVESTIGATION OBSERVED UNIT BIOLOGICAL REF.
VALUES INTERVAL
HEMATOLOGY
P-TIME (PROTHROMBIN TIME)
(PROTHROMBIN TIME)CONTROL 13.2 Sec
Photometric
(PROTHROMBIN TIME) Test 15.3 Sec 12.5-15.5
Photometric
Comments: International Normalised Ratio (INR) is the most recommendation method for monitoring of Oral anticoagulants. The dose of the
anticoagulant can be adjusted betweenthe limits by two parallel biological assays: 1-Prothrombin Time which explorates thethe extrinsic
coagulation pathway. 2-Activated partial thromboplastin time which takes into account any effect of deficiencies induced by the drug on the
intrinsic pathway.
--------------------------End of The Report--------------------------
ORIGINAL FINAL REPORT REVISED REPORT Signed By Pathologist
Checked by :- Lab Technician
Page 1 of 1
